Literature DB >> 25115975

Unhelpful information about adverse drug reactions.

Kirin Tan1, Keith J Petrie2, Kate Faasse2, Mark J Bolland1, Andrew Grey3.   

Abstract

Mesh:

Year:  2014        PMID: 25115975     DOI: 10.1136/bmj.g5019

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  14 in total

1.  Stroke patients' support: evaluation of knowledge, practices and training needs of French community pharmacists.

Authors:  Sophie Khettar; Marie Viprey; Julie Haesebaert; Sophie Jacquin-Courtois; Jacques Luauté; Laura Mechtouff; Laurent Derex; Gilles Rode; Claude Dussart; Audrey Janoly-Dumenil
Journal:  Int J Clin Pharm       Date:  2021-01-02

2.  [Biosimilars and the nocebo effect].

Authors:  J Braun; S Tsiami; B Buehring; D Kiefer; I Andreica; X Baraliakos; U Kiltz
Journal:  Z Rheumatol       Date:  2020-04       Impact factor: 1.372

3.  The Unintended Consequences of Adverse Event Information on Medicines' Risks and Label Content.

Authors:  Giovanni Furlan; David Power
Journal:  Pharmaceut Med       Date:  2020-11-16

Review 4.  Biosimilar insulins: guidance for data interpretation by clinicians and users.

Authors:  L Heinemann; P D Home; M Hompesch
Journal:  Diabetes Obes Metab       Date:  2015-07-01       Impact factor: 6.577

5.  Participant-Reported Symptoms and Their Effect on Long-Term Adherence in the International Breast Cancer Intervention Study I (IBIS I).

Authors:  Samuel George Smith; Ivana Sestak; Anthony Howell; John Forbes; Jack Cuzick
Journal:  J Clin Oncol       Date:  2017-06-29       Impact factor: 44.544

6.  Glycaemic control and hypoglycaemia during 12 months of randomized treatment with insulin glargine 300 U/mL versus glargine 100 U/mL in people with type 1 diabetes (EDITION 4).

Authors:  Philip D Home; Richard M Bergenstal; Geremia B Bolli; Monika Ziemen; Maria Rojeski; Melanie Espinasse; Matthew C Riddle
Journal:  Diabetes Obes Metab       Date:  2017-08-08       Impact factor: 6.577

7.  Comparison of tolerability and adverse symptoms in oxcarbazepine and carbamazepine in the treatment of trigeminal neuralgia and neuralgiform headaches using the Liverpool Adverse Events Profile (AEP).

Authors:  E Besi; D R Boniface; R Cregg; J M Zakrzewska
Journal:  J Headache Pain       Date:  2015-09-03       Impact factor: 7.277

8.  Drug-disease and drug-drug interactions: systematic examination of recommendations in 12 UK national clinical guidelines.

Authors:  Siobhan Dumbreck; Angela Flynn; Moray Nairn; Martin Wilson; Shaun Treweek; Stewart W Mercer; Phil Alderson; Alex Thompson; Katherine Payne; Bruce Guthrie
Journal:  BMJ       Date:  2015-03-11

9.  Understanding adverse drug reactions in package leaflets - an exploratory survey among health care professionals.

Authors:  Viktoria Mühlbauer; Ingrid Mühlhauser
Journal:  BMC Health Serv Res       Date:  2015-11-10       Impact factor: 2.655

10.  Does different information disclosure on placebo control affect blinding and trial outcomes? A case study of participant information leaflets of randomized placebo-controlled trials of acupuncture.

Authors:  Soyeon Cheon; Hi-Joon Park; Younbyoung Chae; Hyangsook Lee
Journal:  BMC Med Res Methodol       Date:  2018-01-18       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.